Data / Federal awards / NAICS 325412 / BIOCRYST PHARMACEUTICALS INC
BIOCRYST PHARMACEUTICALS INC: 18 federal contract awards, $-26.1 million obligated (FY2024 to FY2027)
BIOCRYST PHARMACEUTICALS INC (UEI MGXADJ6SCLJ5), Durham, NC, received 18 federal prime contract awards with $-26.1 million obligated in fiscal years 2024 to 2027, from 2 agencies under 4 NAICS codes. Its largest buyer is Department of Veterans Affairs ($2.2 million) and its largest code is NAICS 325412 Pharmaceutical Preparation Manufacturing.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- MGXADJ6SCLJ5UEI
- Durham, NCLocation
- Small BusinessBusiness size
- 18Contract awards
- $-26.1 millionObligated
- 2023-10-27First action in window
- 2026-10-01Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | 15 | $16 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $-3,711,828 |
| 541711 | Research and Development in Biotechnology | 1 | $-8,587,497 |
| 541710 | Research and Development in the Physical, Engineering, and Life Sciences | 1 | $-29,867,448 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Veterans Affairs | 14 | $2.2 million |
| Department of Health and Human Services | 4 | $-28,289,100 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $2.7 million |
| FY2025 | $-28,792,411 |
| FY2026 | $6,624 |
| FY2027 | $0 |
Contract awards
All 18 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50324F80012 | Department of Health and Human Services | Delivery Order | 325412 | PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN)) | $13,877,674 | $13,877,674 | September 30, 2024 | September 29, 2025 | Durham, NC | usaspending.gov |
| 36C26025F0024 | Department of Veterans Affairs | Delivery Order | 325412 | BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO). | $379,939 | $379,939 | October 1, 2024 | September 30, 2025 | Earth City, MO | usaspending.gov |
| 36C26024F0625 | Department of Veterans Affairs | Delivery Order | 325412 | BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP | $379,349 | $379,349 | September 9, 2024 | September 8, 2025 | Earth City, MO | usaspending.gov |
| 36C26026F0006 | Department of Veterans Affairs | Delivery Order | 325412 | PHARM - ORLADEYO | $360,000 | $360,000 | October 1, 2025 | September 30, 2026 | Earth City, MO | usaspending.gov |
| 36C26024F0270 | Department of Veterans Affairs | Delivery Order | 325412 | BULK ORDER ORLADEYO | $357,245 | $357,245 | March 12, 2024 | March 11, 2025 | Earth City, MO | usaspending.gov |
| 36C26025F0070 | Department of Veterans Affairs | Delivery Order | 325412 | BULK ORLADEYO PHARMACEUTICAL | $242,987 | $242,987 | March 12, 2025 | March 11, 2026 | Earth City, MO | usaspending.gov |
| 36C26024F0258 | Department of Veterans Affairs | Delivery Order | 325412 | ORLADEYO 150MG CAPS | $201,722 | $201,722 | March 4, 2024 | October 4, 2024 | Earth City, MO | usaspending.gov |
| 36C26026F0294 | Department of Veterans Affairs | Delivery Order | 325412 | ORLADEYO 150MG CAP | $151,465 | $151,465 | May 19, 2026 | September 30, 2026 | Earth City, MO | usaspending.gov |
| 36C24926F0152 | Department of Veterans Affairs | Delivery Order | 325412 | EMERGENCY ORLADEYO | $30,293 | $30,293 | May 21, 2026 | June 10, 2026 | Durham, NC | usaspending.gov |
| 36C26024F0240 | Department of Veterans Affairs | Delivery Order | 325412 | ORLADEYO EMERGENT | $29,650 | $29,650 | February 20, 2024 | May 20, 2024 | Earth City, MO | usaspending.gov |
| 36C26025F0296 | Department of Veterans Affairs | Delivery Order | 325412 | BULK ORDER ORLADEYO FOR VETERAN CARE. | $29,408 | $29,408 | September 9, 2025 | September 8, 2026 | Earth City, MO | usaspending.gov |
| 36E79721A0015 | Department of Veterans Affairs | BPA | 325412 | BPA FOR RAPIVAB, ORLADEYO | $0 | $10,000,000 | May 19, 2021 | usaspending.gov | ||
| 36E79726A0015 | Department of Veterans Affairs | BPA | 325412 | BPA FOR ORLADEYO AND RAPIVAB | $0 | $93,000,000 | June 3, 2026 | usaspending.gov | ||
| 36F79721D0166 | Department of Veterans Affairs | FSS | 325412 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | $0 | $1,250,000 | May 15, 2021 | usaspending.gov | ||
| 36C26124N0446 | Department of Veterans Affairs | Delivery Order | 325412 | BEROTRALSTAT | $0 | $0 | February 16, 2024 | May 16, 2024 | Durham, NC | usaspending.gov |
| 75N93020C00055 | Department of Health and Human Services | Definitive Contract | 541715 | COVID-19. TO MANUFACTURE AND EVALUATE THE SAFETY, EFFICACY AND TOLERABILITY OF GALIDESIVIR A BROAD SPECTRUM, ANTIVIRAL THERAPEUTIC. | $-3,711,828 | $2,614,652 | September 1, 2020 | September 30, 2022 | Durham, NC | usaspending.gov |
| HHSO100201500007C | Department of Health and Human Services | Definitive Contract | 541711 | IGF::CT::IGF BIOCRYST PHARMACEUTICALS | $-8,587,497 | $11,911,994 | March 31, 2015 | May 31, 2021 | Durham, NC | usaspending.gov |
| HHSO100200700032C | Department of Health and Human Services | Definitive Contract | 541710 | ADVANCE DEVELOPMENT OF NEW ANTIVIRAL AGENT FOR INFLUENZA | $-29,867,448 | $204,984,699 | January 3, 2007 | April 30, 2014 | Birmingham, AL | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 325412 Pharmaceutical Preparation Manufacturing
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541711 Research and Development in Biotechnology
- Open opportunities under NAICS 325412
- Open opportunities under NAICS 541715
Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.